Never Too Late To Operate? Surgery Near End Of Life Is Common, Costly
Nearly 1 in 3 Medicare patients undergo an operation in their final year of life.
FDA Head Vows To Tackle High Drug Prices And Drugmakers ‘Gaming The System’
In an exclusive interview, FDA Commissioner Scott Gottlieb describes what he’s doing to spur competition and bring down drug prices.
Doing More Harm Than Good? Epidemic of Screening Burdens Nation’s Older Patients
Patients are often aggressively screened for cancer, even if they won’t live long enough to benefit.
Tanta atención que duele: terapias y cirugías innecesarias agregan dolor y enfermedad
Las pruebas excesivas de cáncer de tiroides, próstata, seno y piel lleva a muchas personas mayores a someterse a tratamientos que no prolongarán sus vidas, pero que pueden causar dolor y sufrimiento innecesarios.
So Much Care It Hurts: Unneeded Scans, Therapy, Surgery Only Add To Patients’ Ills
Overtreatment of breast cancer and other diseases is pervasive, burdening patients and the health care system with enormous costs and needless suffering.
Cascade of Costs Could Push New Gene Therapy Above $1 Million Per Patient
The costs of using a new class of cancer treatments include far more than the drug’s sticker price.
Algunos pacientes con cáncer de tiroides pueden retrasar la cirugía
Alrededor de un tercio de los pacientes con un tumor de tiroides de crecimiento lento, llamado cáncer de tiroides papilar, son elegibles para retrasar el tratamiento, según un nuevo estudio.
Some Thyroid Cancer Patients Can Safely Delay Surgery
Study suggests that many small tumors are sleepy, not deadly.
Nueva droga contra la leucemia ofrece esperanza, pero a un costo millonario
El tratamiento con una nueva droga del laboratorio Novartis para casos en los que ha fracasado la quimioterapia o el trasplante de médula costaría $649,000.
‘Breakthrough’ Leukemia Drug Also Portends ‘Quantum Leap’ In Cost
A genetically altered cancer drug, based on CAR T-cell therapies, could be a big success with leukemia patients but at a staggering cost.
